These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33076989)

  • 41. Chronic gliosis and behavioral deficits in mice following repetitive mild traumatic brain injury.
    Mannix R; Berglass J; Berkner J; Moleus P; Qiu J; Andrews N; Gunner G; Berglass L; Jantzie LL; Robinson S; Meehan WP
    J Neurosurg; 2014 Dec; 121(6):1342-50. PubMed ID: 25267088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Astaxanthin improves cognitive performance in mice following mild traumatic brain injury.
    Ji X; Peng D; Zhang Y; Zhang J; Wang Y; Gao Y; Lu N; Tang P
    Brain Res; 2017 Mar; 1659():88-95. PubMed ID: 28048972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GPR40 receptor activation leads to CREB phosphorylation and improves cognitive performance in an Alzheimer's disease mouse model.
    Khan MZ; Zhuang X; He L
    Neurobiol Learn Mem; 2016 May; 131():46-55. PubMed ID: 26976092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice.
    Hou TT; Yang HY; Wang W; Wu QQ; Tian YR; Jia JP
    J Alzheimers Dis; 2018; 62(4):1803-1813. PubMed ID: 29614663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease.
    Zhu H; Xue X; Wang E; Wallack M; Na H; Hooker JM; Kowall N; Tao Q; Stein TD; Wolozin B; Qiu WQ
    Neuropharmacology; 2017 Jun; 119():170-181. PubMed ID: 28363773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic administration of nilvadipine delays photoreceptor degeneration of heterozygous retinal degeneration slow (rds) mouse.
    Takeuchi K; Nakazawa M; Mizukoshi S
    Exp Eye Res; 2008 Jan; 86(1):60-9. PubMed ID: 17976582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):151-5. PubMed ID: 8869150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metallothionein III Decreases the Proliferation of Astrocytes and Enhances Pathological Improvements in a Mouse Model of Alzheimer's Disease.
    Lv J; Wang F; Wang T; Shi Y
    Discov Med; 2024 Jun; 36(185):1221-1230. PubMed ID: 38926108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Ca2+ antagonists on motor activity and the dopaminergic system in aged mice.
    Kurosaki R; Akasaka M; Michimata M; Matsubara M; Imai Y; Araki T
    Neurobiol Aging; 2003; 24(2):315-9. PubMed ID: 12498965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nilvadipine inhibits acute rise of aqueous flare and intraocular pressure induced by prostaglandin E2 in pigmented rabbits.
    Zhang XY; Hiraki S; Hayasaka S
    Ophthalmic Res; 1998; 30(3):135-41. PubMed ID: 9618717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical correlates to assist with chronic traumatic encephalopathy diagnosis: Insights from a novel rodent repeat concussion model.
    Thomsen GM; Ko A; Harada MY; Ma A; Wyss L; Haro P; Vit JP; Avalos P; Dhillon NK; Cho N; Shelest O; Ley EJ
    J Trauma Acute Care Surg; 2017 Jun; 82(6):1039-1048. PubMed ID: 28520686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective action of a calcium antagonist, nilvadipine, against aortic calcium deposition--a pathogenic factor in atherosclerosis.
    Mutoh S; Nomoto A; Sekiguchi C; Yamaguchi I
    Atherosclerosis; 1988 Oct; 73(2-3):181-9. PubMed ID: 3263872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolonged inhibitory effects of nilvadipine (FR34235) following washout in isolated rabbit aorta and mesenteric artery.
    Furuta T
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):134-8. PubMed ID: 2452305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.
    Choi SH; Aid S; Caracciolo L; Minami SS; Niikura T; Matsuoka Y; Turner RS; Mattson MP; Bosetti F
    J Neurochem; 2013 Jan; 124(1):59-68. PubMed ID: 23083210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repeated mild traumatic brain injuries impair visual discrimination learning in adolescent mice.
    Pinkowski NJ; Guerin J; Zhang H; Carpentier ST; McCurdy KE; Pacheco JM; Mehos CJ; Brigman JL; Morton RA
    Neurobiol Learn Mem; 2020 Nov; 175():107315. PubMed ID: 32980477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repeated mild traumatic brain injury in female rats increases lipid peroxidation in neurons.
    Yates NJ; Lydiard S; Fehily B; Weir G; Chin A; Bartlett CA; Alderson J; Fitzgerald M
    Exp Brain Res; 2017 Jul; 235(7):2133-2149. PubMed ID: 28417146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes.
    Niwa T; Shiraga T; Hashimoto T; Kagayama A
    Biol Pharm Bull; 2004 Mar; 27(3):415-7. PubMed ID: 14993813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice.
    Morin A; Mouzon B; Ferguson S; Paris D; Saltiel N; Browning M; Mullan M; Crawford F
    Sci Rep; 2021 Apr; 11(1):7900. PubMed ID: 33846461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel multipotent AChEI-CCB attenuates hyperhomocysteinemia-induced memory deficits and Neuropathologies in rats.
    Xia Y; Liu R; Chen R; Tian Q; Zeng K; Hu J; Liu X; Wang Q; Wang P; Wang XC; Wang JZ
    J Alzheimers Dis; 2014; 42(3):1029-39. PubMed ID: 25024319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Down-Regulation of Mir-107 Worsen Spatial Memory by Suppressing SYK Expression and Inactivating NF-ΚB Signaling Pathway.
    Hu W; Wen L; Cao F; Wang Y
    Curr Alzheimer Res; 2019; 16(2):135-145. PubMed ID: 30543171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.